Riskpilot← Back to searchSign inGet full accessKAPPA BIOSCIENCE AS
ASActiveOrg 990476357Silurveien 2B, 4. Etasje, 0380 OsloManufacture of other food products n.e.c. · NACE 1089Est. 200646 employees
Revenue 2024
NOK 477,3M
+40% vs 2023
EBITDA margin
38.2%
+53% vs 2023
Equity ratio
41.6%
Financial strength
Net profit 2024
NOK 130,8M
+41% vs 2023
| Revenue | NOK 477,3M | +40% |
| EBITDA | NOK 182,5M | +53% |
| Net profit | NOK 130,8M | +41% |
| Total assets | NOK 711,7M | +24% |
| Equity | NOK 296,2M | -1% |
| Employees | 46 | — |
Legal name
KAPPA BIOSCIENCE AS
Org number
990476357
Legal form
Aksjeselskap
NACE code
1089 · Manufacture of other food products n.e.c.
Founded
11. desember 2006
Share capital
NOK 1 520 697
Employees
46 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Utvikling, produksjon og salg av produkter innen næringsmiddel, kosttilskudd og medisin og videre, samt investeringer av enhver art og deltagelse i andre selskap.
Address
Silurveien 2B, 4. Etasje, 0380 Oslo
Phone
+4721080680
Email
info@kappabio.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 525 | 595 | 3 465 | 7 905 | 11 168 | 20 071 | 35 390 | 51 442 | 61 469 | 114 759 | 138 377 | 203 569 | 238 196 | 300 260 | 341 096 | 477 255 |
| Staff expenses | −1 358 | −3 104 | −4 209 | −4 536 | −4 408 | −4 709 | −6 734 | −7 417 | −9 067 | −10 178 | −15 563 | −21 314 | −24 919 | −43 992 | −30 350 | −0 |
| EBITDA | −3 948 | −12 263 | −7 514 | −2 148 | −3 995 | 1 062 | 1 982 | 10 342 | 6 565 | 22 918 | 41 044 | 68 424 | 57 867 | 69 595 | 119 158 | 182 506 |
| Depreciation & amort. | −0 | −0 | −21 | −48 | −48 | −70 | −77 | −56 | −1 122 | −2 223 | −2 438 | −3 077 | −4 321 | −7 269 | −3 350 | −12 419 |
| EBIT | −3 948 | −12 263 | −7 535 | −2 195 | −4 043 | 993 | 1 905 | 10 286 | 5 444 | 20 695 | 38 606 | 65 346 | 53 546 | 62 326 | 115 808 | 170 087 |
| Net financials | 54 | 98 | −7 | −41 | −295 | 46 | −69 | 447 | 438 | −93 | −1 974 | −2 364 | 15 419 | 4 977 | −3 101 | −628 |
| Profit before tax | −3 894 | −12 165 | −7 542 | −2 237 | −4 338 | 1 039 | 1 837 | 10 733 | 5 882 | 20 602 | 36 632 | 62 982 | 68 965 | 67 303 | 112 706 | 169 458 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −6 277 | 4 452 | 7 828 | 13 865 | 8 624 | 15 201 | 19 605 | −0 |
| Net profit | −3 894 | −12 165 | −7 542 | −2 237 | −4 338 | 1 039 | 1 837 | 10 733 | 12 158 | 16 150 | 28 803 | 49 117 | 60 342 | 52 102 | 93 102 | 130 839 |
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4 679 | 6 360 | 5 452 | 8 587 | 15 280 | 12 467 | 19 717 | 66 831 | 108 010 | 133 551 | 202 348 | 259 039 | 358 271 | 470 980 | 574 295 | 711 705 |
| Equity | 3 144 | — | 1 508 | 3 320 | 6 048 | 7 089 | 9 289 | 51 252 | 67 647 | 85 203 | 114 007 | 179 934 | 230 199 | 254 083 | 298 715 | 296 174 |
| Long-term debt | 0 | 0 | 0 | 2 000 | 4 000 | 3 835 | 3 035 | 2 200 | 10 819 | 7 424 | 5 455 | 1 555 | 30 158 | 71 244 | 183 689 | 174 788 |
| Short-term debt | 1 535 | 3 370 | 3 943 | 3 267 | 5 232 | 1 543 | 7 393 | 13 379 | 29 544 | 40 924 | 82 887 | 77 550 | 91 208 | 145 652 | 87 245 | 240 744 |
| Total debt | 1 535 | 3 370 | 3 943 | 5 267 | 9 232 | 5 378 | 10 428 | 15 579 | 40 363 | 48 348 | 88 342 | 79 105 | 121 366 | 216 897 | 270 934 | 415 531 |
EBITDA margin
38.2%
This company
15.8%
Market median
+142% vs market
20092024
Equity ratio
41.6%
This company
38.2%
Market median
+9% vs market
20092024
Return on equity
44.2%
This company
18.4%
Market median
+140% vs market
20092024
Net profit margin
27.4%
This company
8.1%
Market median
+238% vs market
20092024
Asset turnover
0.67×
This company
1.12×
Market median
-40% vs market
20092024
Debt / equity
1.40×
This company
0.62×
Market median
-126% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KS Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
EG Chief Executive Officer | Chief Executive Officer | 2009 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Kechu Bidco As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Kechu Bidco As
KAPPA BIOSCIENCE AS Board members of KAPPA BIOSCIENCE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kai Schröder | Chief Executive Officer | 0 companies |
| Egil Greve | Chief Executive Officer | 0 companies |
| Bjarne Kveim Lie | Board of Directors | 0 companies |
| Manfred Ludwig Eggersdorfer | Board of Directors | 0 companies |
| Johanna Maria Rydén | Board of Directors | 0 companies |
| Bo Christer Åberg | Chairman | 0 companies |
| Charlotte Sofie Bergsagel Berg-Svendsen | Board of Directors | 0 companies |
| Theodore Lee Harris | Chairman | 0 companies |
| Job Leonard Anthonie Van Gunsteren | Board of Directors | 0 companies |
| Per Parham Benisi | Board of Directors | 0 companies |
| Johan Frederik Blichfeldt Gjesdahl | Board of Directors | 0 companies |